News › Pharma  ·  28 Apr 2026, 8:18 AM IST  ·  3 months ago

Bullish RSI: SUNPHARMA, Shyam Metalics Show Strong Momentum

VolatileBias: Bullish +5585% confidencePharmaBullish read

In one line — Bullish bias for Sun Pharma and Shyam Metalics; look for entry points on minor pullbacks or breakout confirmations.

Bearish
Bullish
−1000+55+100

Source: Economic Times · AI-summarised by Anadi · Updated 28 Apr 2026, 9:01 AM IST

Pharmatilt positive

What Happened

Sun Pharma (SUNPHARMA) and Shyam Metalics (SHYAMMETL) are among six Nifty 500 stocks that exhibited a bullish Relative Strength Index (RSI) upswing on April 27, following gains of over 6%. The RSI moving above the 50 level is a key technical indicator of strengthening momentum.

Why It Matters (for you)

For traders, a bullish RSI upswing, especially after a significant price gain, is a strong signal of positive momentum. It suggests that buying pressure is increasing and the stock may continue its upward trajectory, offering potential short-term gains.

Impact on Indian Markets

Sun Pharma (SUNPHARMA) and Shyam Metalics (SHYAMMETL) are likely to attract increased buying interest from momentum traders. This could lead to further price appreciation and higher trading volumes in the near term, potentially outperforming the broader market.

What Traders Should Watch Next

Traders should monitor the daily price action and volume of Sun Pharma and Shyam Metalics for confirmation of continued momentum. Look for the RSI to sustain above 50 and for the stock prices to hold above key support levels. Any signs of divergence or reversal patterns would be a signal to re-evaluate.

Key Evidence

  • Six Nifty 500 stocks, including Sun Pharma and Shyam Metalics, showed a bullish RSI upswing on April 27.
  • These stocks gained over 6% before the RSI upswing.
  • The move above the 50 RSI level signals strengthening momentum.
  • Risk flag: Overbought conditions if RSI goes too high
  • Risk flag: Broader market correction